Reformulation improves adherence by reducing pill burden and side effects, enhancing real-world usability and align therapies with diverse patient needs.
- Regulatory Attention To Human Factors: How Much Is There?
- Gaining An Edge In GLP-1 Production
- Transendocardial Cell Delivery In Post‑Acute Myocardial Infarction
- Where Drug Delivery Falls Short And What The Industry Should Do Next
- BCS Class IV: Rescuing Hard To Deliver Molecules With Nanoformulation
- Patient-Centric Drug Delivery: Do Possible And Preferable Always Align?
- Expanding The IV → SC Framework: What Reformulation Really Means
- AI: The Inflection Point In Retinal Drug Discovery, Development, And Delivery
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Best Practices For Ensuring Quality In Biologic Products
New biologic therapies have new challenges in their packaging and delivery systems because of their complexities, higher stability risks, and larger sizes.
-
Self-Injection Of Biologics Made Easy
Ready-to-Use (RTU) 3mL cartridge-based, single-use Pen Devices are specifically designed to ensure consistency of delivery for high-volume, high-viscosity injectable drug delivery systems.
-
Lyophilization Contract Manufacturing Services: What To Know
Explore the best ways to optimize your lyophilization cycle and the benefits of partnering with an experienced pharmaceutical contract manufacturing services provider.
-
Innovative ASD Technology Improves Abandoned Cancer Medication
Review this case to learn how one solid dispersion technology lowered patients' pill burdens and demonstrated an improved therapeutic response for Galeterone.
-
Early Decisions To De-Risk The Transition To Combination Products
The injectable product development landscape is changing, and the pressure to accelerate timelines remains constant. What can you do to overcome all the uncertainty and risk?
-
High Potent Formulation Development In Oncology
Examine the vital role formulation development plays in oncology outsourcing and how sponsors can increase their chances of success with the right CDMO partner.
-
Ophthalmic Drug Delivery
Explore the challenges to effective delivery of drugs to the eye, intricacies of ophthalmic drug delivery, and advantages of nanoparticles as an enabling technology for ocular drug-delivery systems.
-
Faster From Formulation To Fill/Finish
Optimize your speed to clinic by securing a development and aseptic fill/finish partner to support your applications with the right manufacturing equipment, communications, and SOPs.
-
Designing Delivery Devices For Older Adults With Cognitive Impairment
Leverage our insights to improve your human factors studies and ensure the effective inclusion of older adults with mild cognitive impairment.
-
Delivering The Promise Of Gene Therapy
Gene therapies rely on efficient, precise methods of delivering genetic material. Examine how combining polymeric nanoparticles with CRISPR therapies is increasing the potential for improved treatment.
TOM'S TAKES ON DRUG DELIVERY
TALKING WITH TOM VIDEOCASTS
DELIVERED BY DEGRAZIO
-
6 Packaging And Delivery Challenges For Biologic Therapies
In this article, Fran DeGrazio identifies six aspects of biologics-based therapy packaging and delivery that, if addressed, may help to ensure successful product development and lifecycle management. They include 1) chemical compatibility with device functionality, 2) long-acting formulations, 3) product stability, 4) primary packaging and device integration, 5) cold storage, and 6) higher concentrations and viscosities.

